Science Explorer Interactive view Map
Company · Suwon · South Korea

PanGen Biotech (South Korea)

Research works
20
▲ 6% vs 2013–17
Citations
369
18.4 per fractional work
Top-10% rate
19.7%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: PanGen Biotech (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 11.33× its world share, 3 worksBiochemistry, Geneti…Engineering: 0.54× its world share, 0 worksEngineeringEnvironmental Science: 0.68× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.78× its world share, 0 worksMaterials ScienceMedicine: 1.31× its world share, 1 worksMedicineBusiness, Management and Accounting: 0.06× its world share, 0 worksBusiness, Management…world share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 11.3×. Every wedge is a field page.

Which keywords describe research at PanGen Biotech (South Korea)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, AAV, Viral Vectors, Gene Expression, Cell Culture, Glycosylation, Mammalian Cells and Recombinant Protein.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 10 words, with their numbers
  1. Gene Therapy2▲ 35×3 topics
  2. AAV2▲ 119×1 topic
  3. Epidemiology2▲ 1.93×6 topics
  4. Gene Expression2▲ 13×4 topics
  5. Viral Vectors2▲ 119×1 topic
  6. Cell Culture1▲ 63×2 topics
  7. Glycosylation1▲ 31×2 topics
  8. Mammalian Cells1▲ 169×1 topic
  9. Recombinant Protein1▲ 169×1 topic
  10. Oxidative Stress1▲ 2.9×5 topics

Which research topics does PanGen Biotech (South Korea) publish most on?

By volume in 2022–2025: Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects, Herpesvirus Infections and Treatments and Viral Infections and Immunology Research.

  1. 1 Virus-based gene therapy research Genetics 1 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  3. 3 Herpesvirus Infections and Treatments Epidemiology 0 works
  4. 4 Viral Infections and Immunology Research Cardiology and Cardiovascular Medicine 0 works
  5. 5 Pluripotent Stem Cells Research Molecular Biology 0 works
  6. 6 Molecular Biology Techniques and Applications Molecular Biology 0 works
  7. 7 Thermal Radiation and Cooling Technologies Civil and Structural Engineering 0 works
  8. 8 TGF-β signaling in diseases Molecular Biology 0 works
  9. 9 CRISPR and Genetic Engineering Molecular Biology 0 works
  10. 10 Muscle Physiology and Disorders Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.2%not open57.8%

World: 28% of research is openly available.

with international co-authors20.7%domestic only79.3%

World: 19% is written across borders.

How has PanGen Biotech (South Korea)'s research output changed?

Output in 2018–2022 was 6% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Suwon

All research institutions in Suwon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.